What is KnipBio?
KnipBio operates at the intersection of biotechnology and sustainable agriculture, specializing in the development of JUV, an all-natural fermented ingredient engineered to optimize fish feed performance. By focusing on the critical early life stages of aquatic species, the company addresses significant industry challenges, including juvenile survival rates and stress resilience. This holistic nutritional approach not only enhances the biological health of the stock but also drives measurable improvements in farm profitability. As a leader in the aquaculture innovation space, KnipBio leverages advanced fermentation processes to provide high-performance, scalable solutions that meet the increasing global demand for efficient and sustainable protein production.
How much funding has KnipBio raised?
KnipBio has raised a total of $6.3M across 5 funding rounds:
Series A
$1.6M
Private Equity
$2.5M
Series B
$2M
Debt
$150K
Debt
$77K
Series A (2015): $1.6M with participation from Cherrystone Angel Group and Walnut Venture
Private Equity (2016): $2.5M, investors not publicly disclosed
Series B (2017): $2M supported by CherryStone Angel Group and LaunchPad Venture Group
Debt (2020): $150K featuring PPP
Debt (2021): $77K backed by PPP
Key Investors in KnipBio
LaunchPad Venture Group
A prominent network of angel investors providing financial and human capital to early-stage science-driven startups, with a strong focus on fostering long-term entrepreneurial relationships.
CherryStone Angel Group
An active angel investment group that supports innovative ventures through strategic capital and mentorship, focusing on high-growth potential companies.
Walnut Venture
A venture firm dedicated to backing early-stage companies, providing the necessary financial resources to help startups navigate the complexities of market entry and scaling.
What's next for KnipBio?
With a robust history of capital acquisition, KnipBio is entering a critical phase of commercial maturation. The company's strategic roadmap focuses on the widespread adoption of its JUV ingredient across diverse aquatic species, leveraging its proven efficacy in controlled trials to penetrate larger commercial markets. Future growth will likely center on scaling production capabilities to meet international demand while maintaining the high quality standards that have defined its early-stage development. By prioritizing research-backed nutritional solutions, KnipBio is poised to redefine industry benchmarks for fish health and farm-level economic performance, solidifying its position as a cornerstone of modern aquaculture technology.
See full KnipBio company page